{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T09:51:08Z","timestamp":1725961868071},"reference-count":27,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14540","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T10:34:52Z","timestamp":1719570892000},"source":"Crossref","is-referenced-by-count":1,"title":["Combination of microwave ablation and systemic treatments achieve a long survival time for a patient with metachronous advanced double primary lung and colon adenocarcinoma: A case report"],"prefix":"10.3892","volume":"28","author":[{"given":"Yun","family":"Li","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifeng","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangying","family":"Ruan","sequence":"additional","affiliation":[{"name":"Zhejiang Shaoxing Topgen Biomedical Technology Co., Ltd., Shanghai 201321, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoran","family":"Xia","sequence":"additional","affiliation":[{"name":"Zhejiang Shaoxing Topgen Biomedical Technology Co., Ltd., Shanghai 201321, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[{"name":"Zhejiang Shaoxing Topgen Biomedical Technology Co., Ltd., Shanghai 201321, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"key20240805083116_b1-ol-28-3-14540","first-page":"45","article-title":"Epidemiology of lung cancer","volume":"25","author":"Thandra","year":"2021","journal-title":"Contemp Oncol (Pozn)"},{"key":"key20240805083116_b2-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"e0203058","DOI":"10.1371\/journal.pone.0203058","article-title":"Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis","volume":"13","author":"Schad","year":"2018","journal-title":"PLoS One"},{"key":"key20240805083116_b3-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.3390\/cancers13225773","article-title":"Results of radiation therapy as local ablative therapy for oligometastatic non-small cell lung cancer","volume":"13","author":"Billing","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20240805083116_b4-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"700345","DOI":"10.3389\/fonc.2021.700345","article-title":"A lung adenocarcinoma patient with a rare EGFR E709_T710delinsD mutation showed a good response to afatinib treatment: A case report and literature review","volume":"11","author":"Wei","year":"2021","journal-title":"Front Oncol"},{"key":"key20240805083116_b5-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.2147\/CMAR.S255967","article-title":"Concomitant mutations in EGFR 19Del\/L858R mutation and their association with response to EGFR-TKIs in NSCLC patients","volume":"12","author":"Liang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"key20240805083116_b6-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ettinger","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"key20240805083116_b7-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3390\/cancers14030718","article-title":"Management of oligoprogression in patients with metastatic NSCLC harboring ALK rearrangements","volume":"14","author":"Pisano","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20240805083116_b8-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.21037\/jtd-22-536","article-title":"Oligoprogression in non-small cell lung cancer: A narrative review","volume":"14","author":"Nguyen","year":"2022","journal-title":"J Thorac Dis"},{"key":"key20240805083116_b9-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"1020296","DOI":"10.3389\/fonc.2022.1020296","article-title":"Image-guided percutaneous ablation for lung malignancies","volume":"12","author":"Shang","year":"2022","journal-title":"Front Oncol"},{"key":"key20240805083116_b10-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"56714","DOI":"10.18632\/oncotarget.18083","article-title":"Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"key":"key20240805083116_b11-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4329\/wjr.v4.i4.128","article-title":"The 7th lung cancer TNM classification and staging system: Review of the changes and implications","volume":"4","author":"Mirsadraee","year":"2012","journal-title":"World J Radiol"},{"key":"key20240805083116_b12-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-1050-2_3","article-title":"Tissue processing and hematoxylin and eosin staining","volume":"1180","author":"Feldman","year":"2014","journal-title":"Methods Mol Biol"},{"key":"key20240805083116_b13-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-1-4939-8935-5_25","article-title":"An introduction to the performance of immunohistochemistry","volume":"1897","author":"Magaki","year":"2019","journal-title":"Methods Mol Biol"},{"key":"key20240805083116_b14-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00432-014-1807-z","article-title":"ARMS for EGFR mutation analysis of cytologic and corresponding lung adenocarcinoma histologic specimens","volume":"141","author":"Liu","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20240805083116_b15-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"75712","DOI":"10.18632\/oncotarget.20095","article-title":"EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer","volume":"8","author":"Nan","year":"2017","journal-title":"Oncotarget"},{"key":"key20240805083116_b16-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N Engl J Med"},{"key":"key20240805083116_b17-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"key":"key20240805083116_b18-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1200\/JCO.2018.78.7994","article-title":"Improvement in overall survival in a randomized study that compared dacomitinib with gefitinib in patients with advanced non-small-cell lung cancer and EGFR-activating mutations","volume":"36","author":"Mok","year":"2018","journal-title":"J Clin Oncol"},{"key":"key20240805083116_b19-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.ccell.2021.07.005","article-title":"Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study","volume":"39","author":"Zhou","year":"2021","journal-title":"Cancer Cell"},{"key":"key20240805083116_b20-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"598265","DOI":"10.3389\/fonc.2021.598265","article-title":"First-generation EGFR-TKI plus chemotherapy versus EGFR-TKI alone as first-line treatment in advanced NSCLC with EGFR activating mutation: A systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Wu","year":"2021","journal-title":"Front Oncol"},{"author":"Chinese Society of Clinical Oncology","key":"key20240805083116_b21-ol-28-3-14540","article-title":"Guidelines of Chinese Society of Clinical Oncology (CSCO) Primary Lung Cancer 2016.V1. People's Medical Publishing House, Beijing, China"},{"key":"key20240805083116_b22-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1056\/NEJMoa1411817","article-title":"AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer","volume":"372","author":"J\u00e4nne","year":"2015","journal-title":"N Engl J Med"},{"key":"key20240805083116_b23-ol-28-3-14540","first-page":"270","article-title":"Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI","volume":"11","author":"Xia","year":"2014","journal-title":"Cancer Biol Med"},{"key":"key20240805083116_b24-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"7039","DOI":"10.21037\/jtd-2019-cptn-08","article-title":"Image guided thermal ablation in lung cancer treatment","volume":"12","author":"Lin","year":"2020","journal-title":"J Thorac Dis"},{"key":"key20240805083116_b25-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","article-title":"Multiple primary tumours: Challenges and approaches, a review","volume":"2","author":"Vogt","year":"2017","journal-title":"ESMO Open"},{"key":"key20240805083116_b26-ol-28-3-14540","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.3390\/diagnostics12081940","article-title":"Synchronous\/metachronous multiple primary malignancies: Review of associated risk factors","volume":"12","author":"Pan","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"key20240805083116_b27-ol-28-3-14540","first-page":"29","article-title":"Colonic metastases from lung carcinoma: A case report and review of the literature","volume":"6","author":"Gonzalez-Tallon","year":"2013","journal-title":"Gastroenterology Res"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:31:25Z","timestamp":1722835885000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6,28]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14540","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"article-number":"407"}}